52w high/low | ₹86.05 / ₹46.5 |
P/E ratio | -162.05 |
Dividend | 0 |
ROE | -6.4 |
ROCE | 0.29 |
Face value | 10 |
Book value | ₹33.82Cr |
Market capital | ₹456.27Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Kerala Ayurvedic Pharmacy has emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company has drawn on the rich experience of its parent companies - Kerala Pharmacy and Pensen Drugs and Pharmaceuticals - which were merged in 1992. The company came out with a public issue in Feb. '95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines. It also envisions setting up a hospital. A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye. The company is in the midst of enhancing the installed capacity at its Athani plant to produce traditional ayurvedic medicines. Moreover, the company proposes to organise and relocate its twelve clinics to cover all the principal districts in Kerala and augment facilities at its clinics in Bombay, Madras, Bangalore and Mangalore.